期刊文献+

基质金属蛋白酶-9表达与胰腺癌生物学行为及预后的相关性研究

Correlation between MMP-9 Expression and Biological Behavior and Prognosis of Pancreatic Cancer
原文传递
导出
摘要 目的:探讨基质金属蛋白酶-9(matrix metalloproteinase-9,MMP-9)的表达与胰腺癌生物学特性及对患者预后的影响。方法:采用免疫组织化学法检测63例原发性胰腺癌及11例癌旁正常组织中MMP-9的表达.比较MMP-9的表达与胰腺癌患者生物学特性及预后的关系。结果:MMP-9阳性表达率为68.3%(43/63),而11例癌旁正常组织无MMP-9表达。MMP-9的表达与肿瘤大小(P=0.014)、分化程度(P=0.039)、TNM分期(P=0.001)、远处转移(P=0.011)及淋巴结转移(P=0.009)显著相关。MMP-9表达阳性者生存时间明显低于阴性表达者(Log-rank检验,x2=32.70,P=0.000)。Cox回归分析表明:分化程度(P=0.000)、TNM分期(P=0.006)、淋巴结转移(P=0.035)及MMP-9过表达(P=0.000)是胰腺癌预后的独立影响因素。结论:MMP-9过表达在胰腺癌的浸润转移中发挥重要作用,过表达提示预后不良.对MMP-9的检测可有效的评估胰腺癌患者的预后。 Objective: To evaluate the relationship between expression of matrix metalloproteinase-9(MMP-9) and its biological characteristic,pognosis in pancreatic cancer patients.Methods:The expression of MMP-9 in 63 patients with pancreatic cancer and in 11 patients with the pancreatic tissue of noncarcinoma was examined by immunohistochemical methods.The expression of MMP-9 was compared with biological characteristics and prognosis of pancreatic cancer.Results: The positive expression rate of MMP-9 was 68.3%(43/63),and there was no expression of MMP-9 in adjacent normal pancreatic tissues.The expressions of MMP-9 were significantly correlated with tumor size(P=0.014),differentiation(P=0.039),TNM stages(P=0.001),distant metastasis(P=0.011) and lymph node metastasis(P=0.009).And the survival time of pancreaic cancer patients with the positive expression of MMP-9 was shorter than the negative expression(Log-rank test,x2=32.70,P=0.000).The Cox regression showed that differentiation(P=0.000),TNM stages(P=0.006),lymph node metastasis(P=0.035),MMP-9 overexpression(P=0.000) were related with prognosis of pancreatic cancer patients.Conclusion: The overexpressions of MMP-9 proteins play important roles in proliferation and progression in pancreatic cancer,the overexpression of MMP-9 suggests the worse prognosis in pancreatic cancer.The examination of MMP-9 is useful in evaluating the prognosis of pancreatic cancer patients.
出处 《现代生物医学进展》 CAS 2011年第8期1518-1521,共4页 Progress in Modern Biomedicine
基金 兰州军区医药卫生科研基金资助项目(LXH-2005019)
关键词 基质金属蛋白酶-9 胰腺癌 预后 matrix metalloproteinase-9 Pancreatic cancer Prognosis
  • 相关文献

参考文献13

  • 1Yu Q, Stamenkovic I. Cell surface-localized matrix metalloproteinase- 9 proteolytically activates TGF-bcta and promotes tumor invasion and angiogenesis [J].Genes Dev,2000,14(2): 163 - 176.
  • 2Somiari SB, Shriver CD, Heckman C, et al. Plasma concentration and activity of matrix mctalloproteinasc-2 and-9 in patients with breast disease, breast cancer and at risk of developing breast cancer [J]. Cancer Lett,2006,233(1):98-107.
  • 3YAO J,XIONG S,KLOSK, et al.Mutiple signling pathways involved in activation of matrix metalloproteinase-9 (MMP-9) by heregulin beta1 in human breast cancer cells [J]. Oncogene, 2001, 20:8066.
  • 4Hart S,Ritzenthaler JD, Sitaraman SV, eta.I Fibronectin increases matrix metalloproteinasc-9 expression through activation of c-Fos via extracellular-rcgulated kinase and phosphatidylinositol3-kinase pathways in human lung carcinoma cells[J].J Biol Chem,2006,281(40): 29614-29624.
  • 5Jin JS,Hsich DS, Lin YF, et al. Increasing expression of extracellular matrix metalloprotease inducer in renal cell carcinoma: tissuemicroar- ray analysis of immunostaining score with clinicopathological parame- ters[J].IntJUrol,2006,13(5):573-580.
  • 68odey B,Bodcy JB,Siegel SE,et al.Prognostic significance of matrix metalloproteinase expression in colorectal carcinomas.lnVivo, 2000,14:659-666.
  • 7肖敏,陈婕,余晓云,侯晓华.Angiopoietin-2,MMP-9和TIMP-1在胰腺癌中的表达及其与胰腺癌侵袭转移的关系[J].临床消化病杂志,2006,18(4):216-218. 被引量:3
  • 8SenotaA, Itoh F, YamamotoH, AdachiY et al. Relation of mateilysinm- essengerRNA exprwssion with invasive activity in human gasteic cancer[J].Clin ExpMetastasis, 1998, 16:313-321.
  • 9KoumuraH, SugiyamaY,KuniedaK,et al. Significance in gene expressi- on of matix metalloprotcinase-9, urokinase-type plasminogen activator and tissue inhibitor of metalloprotcinasc formetastases of gastric and/or colorcctal canccr[J].Gan ToKagaku Ryoho, 1997, 24(2)324.
  • 10Tang ZY. Studies on small pancreatic carcinoma clinical aspect and molecular biology[J]. Hepatol Rapid Literat Rev, 1996; 26:11.

二级参考文献1

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部